Signals
Diabetic Eye Screening Is Becoming Risk-Based
England’s diabetic eye screening changes show how population screening is moving from fixed annual invitations toward risk-based intervals, surveillance pathways and OCT-supported triage.
MS Monitoring Starts Moving Beyond the MRI Bottleneck
Latin America Challenges the Dementia Biomarker Evidence Gap
China’s Alzheimer’s Blood-Test Rollout Turns Diagnosis Into an Access Market
Alzheimer’s Blood Testing Moves Toward Routine Care
Oncology Trials Still Do Not Match the Patients They Will Treat
Cancer Pharmacogenomics Exposes an Ancestry Gap in Routine Testing
Biomarker Testing Is Rising, But Eligibility Still Gets Lost
Colon Cancer MRD Testing Is Nearing the Access Threshold
